IL1B and Alzheimer disease: Some cytokines (IL-1β, IL-6, and TNF-α) increase the risk of AD; however, deletion of these cytokines treats the neurotoxic effects of Aβ plaques and rescues recognition impairments (Minter et al., 2016).